<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Fuchs Heterochromic Iridocyclitis - EyeWiki</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"mdy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"ZAVjVoN61eVOGif604Z2qQAAAAw","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Fuchs_Heterochromic_Iridocyclitis","wgTitle":"Fuchs Heterochromic Iridocyclitis","wgCurRevisionId":87483,"wgRevisionId":87483,"wgArticleId":1171,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles","Glaucoma","Uveitis"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Fuchs_Heterochromic_Iridocyclitis","wgRelevantArticleId":1171,"wgIsProbablyEditable":!1,"wgRelevantPageIsProbablyEditable":!1,"wgRestrictionEdit":[],
"wgRestrictionMove":[],"sdgDownArrowImage":"/w/extensions/SemanticDrilldown/skins/down-arrow.png","sdgRightArrowImage":"/w/extensions/SemanticDrilldown/skins/right-arrow.png","wgCiteDrawerEnableDesktop":!1,"wgCiteDrawerEnableMobile":!0,"wgCiteDrawerTheme":"dark","wgPageFormsTargetName":null,"wgPageFormsAutocompleteValues":[],"wgPageFormsAutocompleteOnAllChars":!1,"wgPageFormsFieldProperties":[],"wgPageFormsCargoFields":[],"wgPageFormsDependentFields":[],"wgPageFormsCalendarValues":[],"wgPageFormsCalendarParams":[],"wgPageFormsCalendarHTML":null,"wgPageFormsGridValues":[],"wgPageFormsGridParams":[],"wgPageFormsContLangYes":null,"wgPageFormsContLangNo":null,"wgPageFormsContLangMonths":[],"wgPageFormsHeightForMinimizingInstances":800,"wgPageFormsShowOnSelect":[],"wgPageFormsScriptPath":"/w/extensions/PageForms","edgValues":[],"wgPageFormsEDSettings":null,"wgAmericanDates":!0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},
"srfFilteredConfig":null,"wgEditSubmitButtonLabelPublish":!1};RLSTATE={"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","mediawiki.ui.button":"ready","skins.chameleon":"ready","zzz.ext.bootstrap.styles":"ready","mediawiki.toc.styles":"ready","ext.CookieWarning.styles":"ready","oojs-ui-core.styles":"ready","oojs-ui.styles.indicators":"ready","mediawiki.widgets.styles":"ready","oojs-ui-core.icons":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.srf.styles":"ready","ext.smw.style":"ready","ext.smw.tooltip.styles":"ready"};RLPAGEMODULES=["ext.smw.style","ext.smw.tooltips","ext.cite.ux-enhancements","smw.entityexaminer","site","mediawiki.page.startup","mediawiki.page.ready","mediawiki.toc","ext.citedrawer.main","ext.CookieWarning","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eyeWiki","ext.eyeWiki.slideshow","sentry.init","ext.bootstrap.scripts"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.CookieWarning.styles%7Cext.cite.styles%7Cext.visualEditor.desktopArticleTarget.noscript%7Cmediawiki.toc.styles%7Cmediawiki.ui.button%7Cmediawiki.widgets.styles%7Coojs-ui-core.icons%2Cstyles%7Coojs-ui.styles.indicators%7Cskins.chameleon%7Czzz.ext.bootstrap.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.smw.style%7Cext.smw.tooltip.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.srf.styles&amp;only=styles&amp;skin=chameleon"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=chameleon"></script>
<style>#mw-indicator-mw-helplink {display:none;}</style>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=chameleon"/>
<meta name="generator" content="MediaWiki 1.35.8"/>
<meta name="description" content="Fuchs’ Heterochromic Iridocyclitis (FHI), also known as Fuchs’ uveitis syndrome (FUS), was first described in 1906 by Austrian ophthalmologist, Ernst Fuchs, who reported a series of 38 patients with iris heterochromia, cyclitis, and cataract.&amp;#91;1&amp;#93; Since then, FHI has been further characterized as a constellation of clinical findings, which classically includes low-grade unilateral anterior inflammation with stellate keratic precipitates (KP), iris heterochromia, and prominent iris and angle vessels that bleed after paracentesis (Amsler sign).&amp;#91;2&amp;#93;"/>
<meta name="date" content="2022-12-19"/>
<meta name="WT.seg_1" content="0"/>
<meta name="google-site-verification" content="mtQvMIGqpWB4oyYM5mux15MHU-3qWI0bWtyRa2b5rlk"/>
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/>
<link rel="alternate" type="application/rdf+xml" title="Fuchs Heterochromic Iridocyclitis" href="/w/index.php?title=Special:ExportRDF/Fuchs_Heterochromic_Iridocyclitis&amp;xmlmime=rdf"/>
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="EyeWiki (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="https://eyewiki.org/w/api.php?action=rsd"/>
<link rel="preconnect" href="https://fonts.gstatic.com">
<link href="https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,400&display=swap" rel="stylesheet">
<!-- Favicons MEYE-108 -->
<link rel="apple-touch-icon" sizes="120x120" href="/w/extensions/EyeWiki/favicons/apple-touch-icon.png">
<link rel="icon" type="image/png" sizes="32x32" href="/w/extensions/EyeWiki/favicons/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="16x16" href="/w/extensions/EyeWiki/favicons/favicon-16x16.png">
<link rel="manifest" href="/w/extensions/EyeWiki/favicons/site.webmanifest">
<link rel="mask-icon" href="/w/extensions/EyeWiki/favicons/safari-pinned-tab.svg" color="#603cba">
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico">
<meta name="msapplication-TileColor" content="#603cba">
<meta name="msapplication-config" content="/w/extensions/EyeWiki/favicons/browserconfig.xml">
<meta name="theme-color" content="#ffffff">
<script> window.interdeal = { "sitekey": "81c701489fb8bb4ab90ca1cb0931f9c5", "Position": "Left", "Menulang": "EN", "domains": { "js": "https://cdn.equalweb.com/", "acc": "https://access.equalweb.com/" }, "btnStyle": { "vPosition": [ "80%", null ], "scale": [ "0.8", "0.8" ], "color": { "main": "#1876c9" }, "icon": { "type": 1, "outline": false } } }; (function(doc, head, body){ var coreCall = doc.createElement('script'); coreCall.src = 'https://cdn.equalweb.com/core/4.3.8/accessibility.js'; coreCall.defer = true; coreCall.integrity = 'sha512-u6i35wNTfRZXp0KDwSb3TntaIKI2ItCt/H/KcYIsBeVbaVMerEQLBnU5/ztfBg9aSW1gg7AN4CqCu9a455jkUg=='; coreCall.crossOrigin = 'anonymous'; coreCall.setAttribute('data-cfasync', true ); body? body.appendChild(coreCall) : head.appendChild(coreCall); })(document, document.head, document.body); </script>
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Fuchs_Heterochromic_Iridocyclitis rootpage-Fuchs_Heterochromic_Iridocyclitis layout-standard skin-chameleon action-view">
	<div class="flex-fill container">
		<div class="row">
			<div class="flex-grow-0 col-12 col-cmln-6 d-flex flex-column flex-md-row w-md-100 justify-content-start align-items-center col">
					<div class="float-left mr-3 mb-2"><a href="//aao.org"><img id="aao-logo" src="/w/extensions/EyeWiki/skins/chameleon/AAO_Logo.png"></a></div>
                		
				<!-- logo and main page link -->
				<div id="p-logo" class="p-logo" role="banner">
					<a href="/Main_Page" title="Visit the main page"><img src="/w/extensions/EyeWiki/skins/chameleon/EyeWiki_Logo.png" alt="EyeWiki"/></a>
				</div>
			</div>
			<div class="ml-auto col-12 col-cmln col">
				<div class="row">
					<div class="col">
						<!-- personal tools -->
						<div class="p-personal pull-right" id="p-personal" >
							<ul class="p-personal-tools" >
								<li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Fuchs+Heterochromic+Iridocyclitis" title="You are encouraged to create an account and log in; however, it is not mandatory" class="pt-createaccount">Create account</a></li>
								<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Fuchs+Heterochromic+Iridocyclitis" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o" class="pt-login">Log in</a></li>
							</ul>
						</div>

					</div>
				</div>
				<div class="row">
					<div class="col">
						<!-- search form -->
						<div  id="p-search" class="p-search pull-right" role="search"  >
							<form  id="searchform" class="mw-search" action="/w/index.php" >
								<input type="hidden" name="title" value=" Special:Search" />
								<div class="input-group">
									<input name="search" placeholder="Search EyeWiki" title="Search EyeWiki [f]" accesskey="f" id="searchInput" class="form-control"/>
									<div class="input-group-append">
										<button value="Go" id="searchGoButton" name="go" type="submit" class="search-btn searchGoButton" aria-label="Go to page" title="Go to a page with this exact name if it exists"></button>
									</div>
								</div>
							</form>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar collapsible mb-3 mt-2 p-1 mt-cmln-0" role="navigation" id="mw-navigation">
					<button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#hbpzytjh7h"></button>
					<div class="collapse navbar-collapse hbpzytjh7h" id="hbpzytjh7h">
						<div class="navbar-nav"><div class="nav-item"><a class="nav-link fas fa-home"  href="/Main_Page">Main Page</a></div><div class="nav-item"><a class="nav-link fas fa-book"  href="/Category:Articles">Articles</a></div><div class="nav-item"><a class="nav-link fas fa-play"  href="/Help:Getting_Started">Getting Started</a></div><div class="nav-item"><a class="nav-link fas fa-question"  href="/Help:Contents">Help</a></div><div class="nav-item"><a class="nav-link fas fa-backward"  href="/Special:RecentChanges">Recent changes</a></div><div class="nav-item"><a class="nav-link fas fa-door-open"  href="#">My Portal</a></div>
						</div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- Content navigation -->
				<div class="mb-3 pagetools p-contentnavigation" id="p-contentnavigation">
					<!-- namespaces -->
					<div id="p-namespaces" class="p-namespaces">
						<div class="tab-group">
							<div id="ca-nstab-main" class="selected"><a href="/Fuchs_Heterochromic_Iridocyclitis" title="View the content page [c]" accesskey="c" class="selected ca-nstab-main">Page</a></div>
							<div id="ca-talk" class="new"><a href="/w/index.php?title=Talk:Fuchs_Heterochromic_Iridocyclitis&amp;action=edit&amp;redlink=1" rel="discussion" title="Discussion about the content page (page does not exist) [t]" accesskey="t" class="new ca-talk">Discussion</a></div>
						</div>
					</div>
					<!-- views -->
					<div id="p-views" class="p-views">
						<div class="tab-group">
							<div id="ca-formedit"><a href="/w/index.php?title=Fuchs_Heterochromic_Iridocyclitis&amp;action=formedit" title="Edit this page with a form [&amp;]" accesskey="&amp;" class="ca-formedit">View form</a></div>
							<div id="ca-viewsource"><a href="/w/index.php?title=Fuchs_Heterochromic_Iridocyclitis&amp;action=edit" title="This page is protected.&#10;You can view its source [e]" accesskey="e" class="ca-viewsource">View source</a></div>
							<div id="ca-history"><a href="/w/index.php?title=Fuchs_Heterochromic_Iridocyclitis&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class="ca-history">History</a></div>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">

			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- start the content area -->
				<div id="content" class="mw-body content"><a id="top" class="top"></a>
					<div id="mw-indicators" class="mw-indicators">
					<div id="mw-indicator-smw-entity-examiner" class="mw-indicator mw-indicator-smw-entity-examiner"><div class="smw-entity-examiner smw-indicator-vertical-bar-loader" data-subject="Fuchs_Heterochromic_Iridocyclitis#0##" data-dir="ltr" data-uselang="" title="Running an examiner in the background"></div></div>
				</div>
						<div class="contentHeader">
						<!-- title of the page -->
						<h1 id="firstHeading" class="firstHeading">Fuchs Heterochromic Iridocyclitis</h1>
						<!-- tagline; usually goes something like "From WikiName" primary purpose of this seems to be for printing to identify the source of the content -->
						<div id="siteSub" class="siteSub">From EyeWiki</div><div id="jump-to-nav" class="mw-jump jump-to-nav">Jump to:<a href="#mw-navigation">navigation</a>, <a href="#p-search">search</a></div>
					</div>
					<div id="bodyContent" class="bodyContent">
						<!-- body text -->

						<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="mw-parser-output"><div id="article-header" data-description2-ignore=""><div id="contest" style="margin-bottom: 6px;">
</div>
<div class="infobox contributors">
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header"><a href="/Property:Authors" title="Property:Authors">Article initiated by</a>:
</div>
<div class="info-section-body"><a href="/User:Brian.C.Tse" title="User:Brian.C.Tse">Brian C. Tse, MD</a>,&#8201;<a href="/User:Sarwat.Salim.SEC" title="User:Sarwat.Salim.SEC">Sarwat Salim MD, FACS</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">All authors and contributors:
</div>
<div class="info-section-body"> <a href="/User:Sarwat.Salim.SEC" title="User:Sarwat.Salim.SEC">Sarwat Salim MD, FACS</a>,&#160;<a href="/User:Brian.C.Tse" title="User:Brian.C.Tse">Brian C. Tse, MD</a>,&#160;<a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a>,&#160;<a href="/User:Daniel.B.Moore" title="User:Daniel.B.Moore">Daniel B. Moore, MD</a>,&#160;<a href="/User:Koushik.Tripathy" title="User:Koushik.Tripathy">Koushik Tripathy, MD (AIIMS), FRCS (Glasgow)</a>,&#160;<a href="/User:Edmund.Tsui" title="User:Edmund.Tsui">Edmund Tsui, MD</a>,&#160;<a href="/User:Galia.deitz" title="User:Galia.deitz">Galia Deitz</a>,&#160;<a href="/User:Leonard.K.Seibold" title="User:Leonard.K.Seibold">Leonard K. Seibold, MD</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Assigned editor:
</div>
<div class="info-section-body"> <a href="/User:Edmund.Tsui" title="User:Edmund.Tsui">Edmund Tsui, MD</a>,&#32;<a href="/User:Leonard.K.Seibold" title="User:Leonard.K.Seibold">Leonard K. Seibold, MD</a></div>
</div><div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Review:
</div>
<div class="info-section-body">Assigned status <b>Up to Date</b>
</div>
</div>&#160;by <a href="/User:Edmund.Tsui" title="User:Edmund.Tsui">Edmund Tsui, MD</a> on Dec 20, 2022.
</div>
<div style="display:none;">
<table cellspacing="5">

<tbody><tr>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Fuchs_Heterochromic_Iridocyclitis&amp;action=formedit">add</a></small>
</td></tr>
<tr>
<th align="right"><b><a href="/Property:Contributing_Editors" title="Property:Contributing Editors">Contributing Editors</a>:</b>
</th>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Fuchs_Heterochromic_Iridocyclitis&amp;action=formedit">add</a></small>
</td></tr>
</tbody></table>  </div>
<div style="display:none;">
<p><br />
</p>
</div>
<div id="local-videos">
</div>
</div>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Disease_Entity"><span class="tocnumber">1</span> <span class="toctext">Disease Entity</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Etiology"><span class="tocnumber">1.1</span> <span class="toctext">Etiology</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Epidemiology"><span class="tocnumber">1.2</span> <span class="toctext">Epidemiology</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-4"><a href="#Diagnosis_Physical_examination"><span class="tocnumber">2</span> <span class="toctext">Diagnosis Physical examination</span></a>
<ul>
<li class="toclevel-2 tocsection-5"><a href="#Clinical_diagnosis"><span class="tocnumber">2.1</span> <span class="toctext">Clinical diagnosis</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#Differential_diagnosis"><span class="tocnumber">2.2</span> <span class="toctext">Differential diagnosis</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-7"><a href="#Management"><span class="tocnumber">3</span> <span class="toctext">Management</span></a></li>
<li class="toclevel-1 tocsection-8"><a href="#Glaucoma"><span class="tocnumber">4</span> <span class="toctext">Glaucoma</span></a></li>
<li class="toclevel-1 tocsection-9"><a href="#References"><span class="tocnumber">5</span> <span class="toctext">References</span></a></li>
</ul>
</div>

<h1><span class="mw-headline" id="Disease_Entity">Disease Entity</span></h1>
<p>Fuchs’ Heterochromic Iridocyclitis (FHI), also known as Fuchs’ uveitis syndrome (FUS), was first described in 1906 by Austrian ophthalmologist, Ernst Fuchs, who reported a series of 38 patients with iris heterochromia, cyclitis, and cataract.<sup id="cite_ref-fuchs_1_1-0" class="reference"><a href="#cite_note-fuchs_1-1">&#91;1&#93;</a></sup> Since then, FHI has been further characterized as a constellation of clinical findings, which classically includes low-grade unilateral anterior inflammation with stellate keratic precipitates (KP), iris heterochromia, and prominent iris and angle vessels that bleed after paracentesis (Amsler sign).<sup id="cite_ref-2" class="reference"><a href="#cite_note-2">&#91;2&#93;</a></sup> 
</p>
<h2><span class="mw-headline" id="Etiology">Etiology</span></h2>
<p>Ernst Fuchs presumed that FHI was caused by a noxious stimulus of unknown origin.<sup id="cite_ref-fuchs_1_1-1" class="reference"><a href="#cite_note-fuchs_1-1">&#91;1&#93;</a></sup> &#160;The exact etiology of FHI is still unknown, and the disease process is likely multifactorial. Historical theories on the cause of FHI have associated it with sympathetic dysfunction, as well as multiple infectious etiologies such as toxoplasma, herpes simplex virus (HSV)<sup id="cite_ref-barequet_9_3-0" class="reference"><a href="#cite_note-barequet_9-3">&#91;3&#93;</a></sup> , chikungunya virus<sup id="cite_ref-4" class="reference"><a href="#cite_note-4">&#91;4&#93;</a></sup>, cytomegalovirus (CMV), and rubella virus (RV). 
</p><p>Sympathetic dysfunction resulting in decreased innervation to stromal melanocytes and iris hypopigmentation was an early proposed theory for the etiology of FHI.<sup id="cite_ref-aggarwal_2_5-0" class="reference"><a href="#cite_note-aggarwal_2-5">&#91;5&#93;</a></sup> <sup id="cite_ref-mohamed_3_6-0" class="reference"><a href="#cite_note-mohamed_3-6">&#91;6&#93;</a></sup> <sup id="cite_ref-lahey_4_7-0" class="reference"><a href="#cite_note-lahey_4-7">&#91;7&#93;</a></sup> The abnormal innervation was thought to account for not only the iris heterochromia, but also the breakdown of the blood-aqueous barrier and subsequent inflammation. However, this theory was dismissed after only 25 of 1746 (1.4%) FHI cases in a retrospective study were found to be associated with Horner’s syndrome.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8">&#91;8&#93;</a></sup> The prevalence of peripheral chorioretinal scars in FHI varies from 7-65% of cases, with most studies noting a prevalence of 10%.<sup id="cite_ref-lahey_4_7-1" class="reference"><a href="#cite_note-lahey_4-7">&#91;7&#93;</a></sup> Multiple studies have reported toxoplasma-like chorioretinal scars in a significantly higher proportion of FHI patients compared to control groups.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9">&#91;9&#93;</a></sup><sup id="cite_ref-10" class="reference"><a href="#cite_note-10">&#91;10&#93;</a></sup> For this reason, an etiologic association between toxoplasmosis and FHI has been investigated, however, no significant association between FHI and humoral or cellular immunity to toxoplasma has been found.<sup id="cite_ref-lahey_4_7-2" class="reference"><a href="#cite_note-lahey_4-7">&#91;7&#93;</a></sup>
</p><p>Both HSV and Chikungunya virus have been linked to FHI due to the isolation of viral DNA and RNA, respectively, from the aqueous humor of patients with FHI. Currently, however, these findings are limited only to case reports.<sup id="cite_ref-:0_11-0" class="reference"><a href="#cite_note-:0-11">&#91;11&#93;</a></sup><sup id="cite_ref-degroot_11_12-0" class="reference"><a href="#cite_note-degroot_11-12">&#91;12&#93;</a></sup>
</p><p>The strongest etiologic theories are those associating CMV and RV with FHI. CMV infection has been found to account for 16-42% of FHI in Asia, whereas in Western countries, FHI is predominantly associated with RV.<sup id="cite_ref-:1_13-0" class="reference"><a href="#cite_note-:1-13">&#91;13&#93;</a></sup><sup id="cite_ref-degroot_11_12-1" class="reference"><a href="#cite_note-degroot_11-12">&#91;12&#93;</a></sup><sup id="cite_ref-14" class="reference"><a href="#cite_note-14">&#91;14&#93;</a></sup><sup id="cite_ref-:0_11-1" class="reference"><a href="#cite_note-:0-11">&#91;11&#93;</a></sup> In one Chinese study, aqueous humor samples were obtained from 35 patients with presumed FHI, 15 of which were found to contain CMV DNA by PCR.<sup id="cite_ref-:1_13-1" class="reference"><a href="#cite_note-:1-13">&#91;13&#93;</a></sup> Aqueous humor and blood of 63 European patients with FHI were examined for RV antibodies in one of the largest series of FHI patients, all of whom were found to have intraocular antibody synthesis against RV.<sup id="cite_ref-15" class="reference"><a href="#cite_note-15">&#91;15&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span></h2>
<p>FHI accounts for 2-11% of all uveitides, although the actual prevalence may be higher, as the entity is probably underdiagnosed given a lack of symptoms in the majority of patients.<sup id="cite_ref-mohamed_3_6-1" class="reference"><a href="#cite_note-mohamed_3-6">&#91;6&#93;</a></sup><sup id="cite_ref-degroot_11_12-2" class="reference"><a href="#cite_note-degroot_11-12">&#91;12&#93;</a></sup><sup id="cite_ref-goldstein_12_16-0" class="reference"><a href="#cite_note-goldstein_12-16">&#91;16&#93;</a></sup><sup id="cite_ref-jones_13_17-0" class="reference"><a href="#cite_note-jones_13-17">&#91;17&#93;</a></sup> There is no race or sex predilection<sup id="cite_ref-arif_14_18-0" class="reference"><a href="#cite_note-arif_14-18">&#91;18&#93;</a></sup> and it typically manifests in early to middle adulthood. 
</p>
<h1><span class="mw-headline" id="Diagnosis_Physical_examination">Diagnosis Physical examination</span></h1>
<div class="thumb tright"><div class="thumbinner" style="width:302px;"><a href="/File:Iris_heterochromia.jpg" class="image"><img alt="" src="/w/images/1/thumb/5/56/Iris_heterochromia.jpg/300px-Iris_heterochromia.jpg" decoding="async" width="300" height="200" class="thumbimage" srcset="/w/images/1/thumb/5/56/Iris_heterochromia.jpg/450px-Iris_heterochromia.jpg 1.5x, /w/images/1/5/56/Iris_heterochromia.jpg 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:Iris_heterochromia.jpg" class="internal" title="Enlarge"></a></div>Figure 1: Iris heterochromia in a patient with Fuchs' Heterochromic Iridocyclitis. Note the lighter colored iris in the affected right eye.</div></div></div>
<p>Patients with FHI are often asymptomatic for many years prior to presentation as, unlike with other anterior uveitides, they typically will have no pain, redness, or photophobia. Presenting complaints are usually secondary to cataract or vitritis. Classically, patients will present with unilateral iris heterochromia and atrophy, KP, low-grade iridocyclitis, and cataract in the absence of posterior synechiae.<sup id="cite_ref-mohamed_3_6-2" class="reference"><a href="#cite_note-mohamed_3-6">&#91;6&#93;</a></sup><sup id="cite_ref-goldstein_12_16-1" class="reference"><a href="#cite_note-goldstein_12-16">&#91;16&#93;</a></sup> Only 5-10% of cases are bilateral.
</p>
<p><b>Iris heterochromia</b> is seen in 75-90% of patients.<sup id="cite_ref-arif_14_18-1" class="reference"><a href="#cite_note-arif_14-18">&#91;18&#93;</a></sup> The lighter-colored iris usually, but not invariably, indicates the affected eye (Figure 1). In patients with lightly colored irides, inverse heterochromia may be present, whereby loss of the pale anterior stroma leads to exposure of darker iris pigment epithelium. Iris atrophy often precedes heterochromia. The atrophic iris takes on a moth-eaten appearance, displaying smooth stromal architecture with loss of iris crypts.</p><div class="thumb tright"><div class="thumbinner" style="width:252px;"><a href="/File:Keratic_precipitates.jpg" class="image"><img alt="" src="/w/images/1/thumb/5/53/Keratic_precipitates.jpg/250px-Keratic_precipitates.jpg" decoding="async" width="250" height="188" class="thumbimage" srcset="/w/images/1/thumb/5/53/Keratic_precipitates.jpg/375px-Keratic_precipitates.jpg 1.5x, /w/images/1/5/53/Keratic_precipitates.jpg 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:Keratic_precipitates.jpg" class="internal" title="Enlarge"></a></div>Figure 2: Keratic precipitates in a patient with Fuchs' Heterochromic Iridocyclitis.</div></div></div><p><b>Low-grade iridocyclitis</b> that is not responsive to steroid therapy is a classic feature of FHI. Despite the persistent inflammation, posterior synechiae are characteristically absent. A mild vitritis with stringy vitreous is also commonly seen without the presence of cystoid macular edema.
</p><p><b>Keratic precipitates</b> are usually fine, stellate, and interconnected by fibrin bridges. In contrast to other types of anterior uveitides where KP tend to cluster inferiorly within Arlt’s triangle, KP in FHI tend to be diffuse, and involve the entire endothelial surface.<sup id="cite_ref-mohamed_3_6-3" class="reference"><a href="#cite_note-mohamed_3-6">&#91;6&#93;</a></sup>
</p><p><b>Cataracts</b> are seen in all types of uveitis, however, they occur with particularly high frequency in FHI. Three-quarters of lens opacities in FHI patients are posterior subcapsular.<sup id="cite_ref-goldstein_12_16-2" class="reference"><a href="#cite_note-goldstein_12-16">&#91;16&#93;</a></sup> FHI should be considered in the differential diagnosis of any unilateral cataract in a young patient in the absence of trauma or steroid use.
</p><p><b>Iris nodules,</b> particularly Koeppe and Busacca nodules, can be seen in FHI and may initially lead to a misdiagnosis of granulomatous uveitis.
</p>
<p><b>Iris crystals</b> are small, refractile iris crystals called Russell bodies, which can be seen on the surface of the iris. Russell bodies are aggregations of spherical immunoglobulin.</p><div class="thumb tright"><div class="thumbinner" style="width:252px;"><a href="/File:Gonioscopic_view.jpg" class="image"><img alt="" src="/w/images/1/thumb/5/5a/Gonioscopic_view.jpg/250px-Gonioscopic_view.jpg" decoding="async" width="250" height="188" class="thumbimage" srcset="/w/images/1/thumb/5/5a/Gonioscopic_view.jpg/375px-Gonioscopic_view.jpg 1.5x, /w/images/1/5/5a/Gonioscopic_view.jpg 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:Gonioscopic_view.jpg" class="internal" title="Enlarge"></a></div>Figure 3: Gonioscopic view showing bridging vessels traversing across the angle in a patient with Fuchs' Heterochromic Iridocyclitis.</div></div></div><p><b>Iris rubeosis</b> can be seen in FHI. Gonioscopy should be performed in these eyes as some of these vessels may traverse over the trabecular meshwork (Figure 3). Furthermore, sclerosis of trabecular meshwork can result, and an inflammatory membrane can form over the angle. Although not pathognomonic for FHI, Amsler’s sign occurs when a hyphema results after paracentesis during cataract surgery, rupturing the vessels crossing the trabecular meshwork. These fragile vessels may also lead to hyphema secondary to pressure from gonioscopy or applanation tonometry during clinical examination.
</p><p><b>Chorioretinal scar</b>s seem to have a higher prevalence in patients with FHI versus other types of anterior uveitis, though there is still no definitive link between toxoplasmosis and FHI, as previously mentioned.
</p>
<h2><span class="mw-headline" id="Clinical_diagnosis">Clinical diagnosis</span></h2>
<p>The diagnosis of FHI is based on a constellation of clinical findings, as there is no diagnostic test. Some have proposed using rubella titers, but this has not gained widespread acceptance or practice. However, workup should be performed to rule out other causes of uveitis. 
</p>
<h2><span class="mw-headline" id="Differential_diagnosis">Differential diagnosis</span></h2>
<p>When considering a diagnosis of FHI, other causes of anterior uveitis should be ruled out if possible. These include uveitis associated with herpes infection in particular, given the potentially similar presentation with iris atrophy and diffuse KP. 
</p><p>Posner-Schlossman Syndrome (glaucomatocyclitic crisis), characterized by recurrent, unilateral spikes in intraocular pressure which a certain degree of anterior chamber inflammation and KP, should be considered in patients with suspicion for FHI. Patients with Posner-Schlossman Syndrome can have a certain degree of iris heterochromia as well, due to the strong association with herpes. Importantly, the inflammation in this condition responds to steroids, with subsequent resolution of elevated intraocular pressure spikes.
</p><p>Other causes of heterochromia should be ruled out as well, including congenital Horner’s syndrome, Waardenburg’s syndrome, congenital iris heterochromia, oculodermal melanosis, diffuse iris melanoma, siderosis, and extensive rubeosis.
</p>
<h1><span class="mw-headline" id="Management">Management</span></h1>
<p><b>Inflammation:</b> Most cases of FHI do not require therapy, with patients generally having a good prognosis despite the persistent inflammation. The expected sequelae of chronic uveitis (posterior synechiae, persistent cystoid macular edema) are usually not seen in FHI. Since most of the inflammation is thought to be a result of blood aqueous barrier breakdown with resultant leakage of cells and protein, corticosteroids are generally ineffective in eliminating the low-grade anterior chamber reaction in FHI and should not be used aggressively. Some advocate a short-course of topical steroids to differentiate FHI from Posner-Schlossman syndrome, but long-term steroids are not indicated.<sup id="cite_ref-mohamed_3_6-4" class="reference"><a href="#cite_note-mohamed_3-6">&#91;6&#93;</a></sup><sup id="cite_ref-goldstein_12_16-3" class="reference"><a href="#cite_note-goldstein_12-16">&#91;16&#93;</a></sup>
</p><p><b>Cataract:</b> Patients with FHI have equivocal or better visual results following cataract extraction compared to other forms of chronic uveitis. Studies have shown phacoemulsification with posterior chamber intraocular lens implantation to be a safe and effective procedure in patients with FHI.<sup id="cite_ref-ram_15_19-0" class="reference"><a href="#cite_note-ram_15-19">&#91;19&#93;</a></sup> The peri-operative management of inflammation varies in FHI, with most surgeons placing patients on topical steroids.<sup id="cite_ref-mohamed_3_6-5" class="reference"><a href="#cite_note-mohamed_3-6">&#91;6&#93;</a></sup> Some clinicians even recommend pre-operative systemic steroids. Markers of severe disease, including severe iris atrophy with transillumination defects, glaucoma, and iris vasculature abnormalities, offer a more guarded post-operative prognosis.<sup id="cite_ref-jones_13_17-1" class="reference"><a href="#cite_note-jones_13-17">&#91;17&#93;</a></sup>
</p><p><b>Vitreous opacification:</b> Patients with FHI can present with vitreous floaters from inflammatory debris, most often in the anterior vitreous. Should these floaters become visually significant, pars plana vitrectomy (PPV) has been shown to be exceedingly effective in improving vision in FHI.<sup id="cite_ref-scott_16_20-0" class="reference"><a href="#cite_note-scott_16-20">&#91;20&#93;</a></sup> In fact, PPV had better results in FHI patients than in those with other forms of uveitis, likely as a result of the less aggressive inflammatory course and lack of cystoid macular edema in FHI. 
</p>
<h1><span class="mw-headline" id="Glaucoma">Glaucoma</span></h1>
<p>Glaucoma is the most sight threatening and challenging complication of FHI. The prevalence of secondary glaucoma has been reported to be anywhere from 9-59% in FHI patients.<sup id="cite_ref-goldstein_12_16-4" class="reference"><a href="#cite_note-goldstein_12-16">&#91;16&#93;</a></sup><sup id="cite_ref-lahey_17_21-0" class="reference"><a href="#cite_note-lahey_17-21">&#91;21&#93;</a></sup> <sup id="cite_ref-jones_18_22-0" class="reference"><a href="#cite_note-jones_18-22">&#91;22&#93;</a></sup> <sup id="cite_ref-liesegang_19_23-0" class="reference"><a href="#cite_note-liesegang_19-23">&#91;23&#93;</a></sup> As is the case in primary open angle glaucoma (POAG), African Americans, as well as elderly patients may be at increased risk for developing secondary glaucoma from FHI.<sup id="cite_ref-tabbut_20_24-0" class="reference"><a href="#cite_note-tabbut_20-24">&#91;24&#93;</a></sup> In addition, time to diagnosis, male sex, presence of iris nodules at baseline, and the presence of a cataract (independent of age) have also been found to increase the risk for ocular hypertension and glaucoma in these patients.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25">&#91;25&#93;</a></sup><sup id="cite_ref-26" class="reference"><a href="#cite_note-26">&#91;26&#93;</a></sup>
</p><p>In most cases of glaucoma secondary to FHI, the etiology is thought to be similar to that of chronic open-angle glaucoma. In some cases, inflammatory debris and nodules may play a role in aqueous outflow obstruction and secondary glaucoma. Other rare mechanisms include peripheral anterior synechiae and angle closure, lens-induced glaucoma such as phacolytic glaucoma, steroid induced glaucoma, and neovascular glaucoma from iris and angle rubeosis.<sup id="cite_ref-jones_18_22-1" class="reference"><a href="#cite_note-jones_18-22">&#91;22&#93;</a></sup> Glaucoma in the setting of FHI is particularly recalcitrant, with 73% failing to respond to maximal medical therapy.<sup id="cite_ref-lahey_4_7-3" class="reference"><a href="#cite_note-lahey_4-7">&#91;7&#93;</a></sup> These patients often require incisional surgery. 
</p><p>In the management of uveitic glaucoma in general, laser therapy (trabeculoplasty, cyclophotocoagulation) is generally avoided due to inconsistent efficacy, as well as high risk for complications such as increased inflammatory response and hypotony. Incisional surgery is often more effective though surgical success rates are largely dependent upon the suppression of inflammation postoperatively. Patients with uveitic glaucoma undergoing incisional surgery often have lower rates of success compared to POAG patients due to a propensity for subconjunctival scarring, and higher rates of postoperative hypotony secondary to ciliary body dysfunction from recurrent inflammation.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27">&#91;27&#93;</a></sup> Minimally invasive glaucoma surgeries (MIGS) are still being evaluated for use in uveitic glaucoma though preliminary data from studies treating these patients with canaloplasty and trabeculotomy, in particular, have yielded promising results. Notably, there is some concern that the narrow lumen of implantable devices such as the iStent and Xen may easily obstruct in uveitis patients due to the presence of inflammatory debris.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28">&#91;28&#93;</a></sup> Trabeculectomy in uveitic glaucoma has been demonstrated to have limited success due to excessive scarring, with a 5 year success rate of 54% without adjuvant anti-metabolite therapy and 67% with a one-time does of 5-fluorouracil.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29">&#91;29&#93;</a></sup><sup id="cite_ref-30" class="reference"><a href="#cite_note-30">&#91;30&#93;</a></sup> &#160;As such, glaucoma drainage implant devices (e.g. Ahmed, Baerveldt, Molteno) are generally the preferred initial surgical option in any uveitic glaucoma, with first year success rates ranging from 77-94%.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31">&#91;31&#93;</a></sup><sup id="cite_ref-32" class="reference"><a href="#cite_note-32">&#91;32&#93;</a></sup><sup id="cite_ref-33" class="reference"><a href="#cite_note-33">&#91;33&#93;</a></sup> &#160;
</p><p>As mentioned, FHI is not typically characterized by severe inflammation<sup id="cite_ref-jones_13_17-2" class="reference"><a href="#cite_note-jones_13-17">&#91;17&#93;</a></sup><sup id="cite_ref-arif_14_18-2" class="reference"><a href="#cite_note-arif_14-18">&#91;18&#93;</a></sup>, and outcomes for trabeculectomy and glaucoma drainage implants have been mixed. One retrospective review found that the success rate for patients with FHI-related glaucoma who underwent trabeculectomy with mitomycin C (MMC) was 90.9% and 62.3% at one and four years, respectively.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34">&#91;34&#93;</a></sup> Success rates from a subsequent study was lower, however, reporting trabeculectomy success amongst FHI patients to be around 58% at one year.<sup id="cite_ref-:2_35-0" class="reference"><a href="#cite_note-:2-35">&#91;35&#93;</a></sup> This same study also showed that deep sclerectomy in FHI patients was equally efficacious compared to trabeculectomy, though did note that the rate of laser goniopuncture in this group was higher compared to other studies on deep sclerectomy.<sup id="cite_ref-:2_35-1" class="reference"><a href="#cite_note-:2-35">&#91;35&#93;</a></sup> Of note, in FHI-related glaucoma there appears to be no benefit to adding subconjunctival bevacizumab to the initial trabeculectomy with MMC.<sup id="cite_ref-36" class="reference"><a href="#cite_note-36">&#91;36&#93;</a></sup>
</p><p>Contrary to uveitic glaucoma in general, studies comparing Ahmed glaucoma valves and trabeculectomy in FHI-related glaucoma do not show a clear trend toward superiority. Two retrospective studies published within one year of each other offer differing conclusions, with Esfandiari et al<sup id="cite_ref-37" class="reference"><a href="#cite_note-37">&#91;37&#93;</a></sup>  finding that Ahmed glaucoma valves had higher success rates than trabeculectomy (85.7% with AGV compared to 41.7% with trabeculectomy), and Nilforushan et al concluding the opposite (9% with AGV compared to 76% with trabeculectomy)<sup id="cite_ref-38" class="reference"><a href="#cite_note-38">&#91;38&#93;</a></sup>. Given the relative paucity of FHI cases within uveitic glaucoma, it is difficult to formulate conclusions to guide treatment based on small retrospective studies. Larger studies with a longer duration of follow-up will be necessary to gain a better understanding of outcomes between glaucoma drainage implant devices and glaucoma filtering surgery in this specific patient population. 
</p>
<h1><span class="mw-headline" id="References">References</span></h1>
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-fuchs_1-1"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-fuchs_1_1-0">1.0</a></sup> <sup><a href="#cite_ref-fuchs_1_1-1">1.1</a></sup></span> <span class="reference-text">Fuchs E. Ueber komplikationen der heterochromia. Z Augenheilkd 1906; 15:191-212.</span>
</li>
<li id="cite_note-2"><span class="mw-cite-backlink"><a href="#cite_ref-2">↑</a></span> <span class="reference-text">Nalçacıoğlu, Pınar, Pınar Çakar Özdal, and Mert Şimşek. 2016. “Clinical Characteristics of Fuchs’ Uveitis Syndrome.” <i>Turkish Journal of Ophthalmology</i> 46 (2): 52–57.</span>
</li>
<li id="cite_note-barequet_9-3"><span class="mw-cite-backlink"><a href="#cite_ref-barequet_9_3-0">↑</a></span> <span class="reference-text">Barequet IS, Li Q, Wang Y, et al. Herpes simplex virus DNA identification from aqueous fluid in Fuchs heterochromic Iridocyclitis. Am J Ophthalmol 2000; 129:672-3.</span>
</li>
<li id="cite_note-4"><span class="mw-cite-backlink"><a href="#cite_ref-4">↑</a></span> <span class="reference-text">Mahendradas, Padmamalini, Rohit Shetty, J. Malathi, and H. N. Madhavan. 2010. “Chikungunya Virus Iridocyclitis in Fuchs’ Heterochromic Iridocyclitis.” <i>Indian Journal of Ophthalmology</i> 58 (6): 545–47.</span>
</li>
<li id="cite_note-aggarwal_2-5"><span class="mw-cite-backlink"><a href="#cite_ref-aggarwal_2_5-0">↑</a></span> <span class="reference-text">Aggarwal RK, Luck J, Coster DJ. Horner’s syndrome and Fuchs’ heterochromic uveitis. Br J Ophthalmol 1994; 78:949.</span>
</li>
<li id="cite_note-mohamed_3-6"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-mohamed_3_6-0">6.0</a></sup> <sup><a href="#cite_ref-mohamed_3_6-1">6.1</a></sup> <sup><a href="#cite_ref-mohamed_3_6-2">6.2</a></sup> <sup><a href="#cite_ref-mohamed_3_6-3">6.3</a></sup> <sup><a href="#cite_ref-mohamed_3_6-4">6.4</a></sup> <sup><a href="#cite_ref-mohamed_3_6-5">6.5</a></sup></span> <span class="reference-text">Mohamed Q, Zamir E. Update of Fuchs’ uveitis syndrome. Curr Opin Ophthalmol 2005; 16:356-63.</span>
</li>
<li id="cite_note-lahey_4-7"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-lahey_4_7-0">7.0</a></sup> <sup><a href="#cite_ref-lahey_4_7-1">7.1</a></sup> <sup><a href="#cite_ref-lahey_4_7-2">7.2</a></sup> <sup><a href="#cite_ref-lahey_4_7-3">7.3</a></sup></span> <span class="reference-text">La Hey E, de Jong PT, Kijlstra A. Fuchs’ heterochromic cyclitis: review of the literature on the pathogenetic mechanisms. Br J Ophthalmol 1994; 78:307-12.</span>
</li>
<li id="cite_note-8"><span class="mw-cite-backlink"><a href="#cite_ref-8">↑</a></span> <span class="reference-text">Lowenfeld IE, Thompson HS. Fuchs’ heterochromic cyclitis: a critical review of the literature, I: clinical characteristics of the syndrome. Surv Ophthalmol 1973; 17:394-457.</span>
</li>
<li id="cite_note-9"><span class="mw-cite-backlink"><a href="#cite_ref-9">↑</a></span> <span class="reference-text">Schwab IR. The epidemiologic association of Fuchs’ heterochromic Iridocyclitis and ocular toxoplasmosis. Am J Ophthalmol 1991; 111:356-62.</span>
</li>
<li id="cite_note-10"><span class="mw-cite-backlink"><a href="#cite_ref-10">↑</a></span> <span class="reference-text">Arffa RC, Schlaegel TF. Chorioretinal scars in Fuchs’ heterochromic Iridocyclitis. Arch Ophthalmol 1984; 102:1153-5.</span>
</li>
<li id="cite_note-:0-11"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:0_11-0">11.0</a></sup> <sup><a href="#cite_ref-:0_11-1">11.1</a></sup></span> <span class="reference-text">Quentin CD, Reiber H. Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol 2004; 138:46-54.</span>
</li>
<li id="cite_note-degroot_11-12"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-degroot_11_12-0">12.0</a></sup> <sup><a href="#cite_ref-degroot_11_12-1">12.1</a></sup> <sup><a href="#cite_ref-degroot_11_12-2">12.2</a></sup></span> <span class="reference-text">de Groot-Mijnes JDF, de visser L, Schuller M, et al. Rubella virus is associated with Fuchs heterochromic Iridocyclitis. Am J Ophthalmol 2006; 141:212-14.</span>
</li>
<li id="cite_note-:1-13"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:1_13-0">13.0</a></sup> <sup><a href="#cite_ref-:1_13-1">13.1</a></sup></span> <span class="reference-text">Chee, Soon-Phaik, and Aliza Jap. 2008. “Presumed Fuchs Heterochromic Iridocyclitis and Posner-Schlossman Syndrome: Comparison of Cytomegalovirus-Positive and Negative Eyes.” <i>American Journal of Ophthalmology</i>146 (6): 883-9.e1.</span>
</li>
<li id="cite_note-14"><span class="mw-cite-backlink"><a href="#cite_ref-14">↑</a></span> <span class="reference-text">Kongyai, N., W. Sirirungsi, K. Pathanapitoon, N. Tananuvat, P. Kunavisarut, P. Leechanachai, J. D. F. de Groot-Mijnes, and A. Rothova. 2012. “Viral Causes of Unexplained Anterior Uveitis in Thailand.” <i>Eye</i> 26 (4): 529–34.</span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><a href="#cite_ref-15">↑</a></span> <span class="reference-text">Ruokonen, Peter C., Sylvia Metzner, Aylin Ucer, Necip Torun, Jörg Hofmann, and Uwe Pleyer. 2010. “Intraocular Antibody Synthesis against Rubella Virus and Other Microorganisms in Fuchs’ Heterochromic Cyclitis.” <i>Graefe s Archive for Clinical and Experimental Ophthalmology</i> 248 (4): 565–71.</span>
</li>
<li id="cite_note-goldstein_12-16"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-goldstein_12_16-0">16.0</a></sup> <sup><a href="#cite_ref-goldstein_12_16-1">16.1</a></sup> <sup><a href="#cite_ref-goldstein_12_16-2">16.2</a></sup> <sup><a href="#cite_ref-goldstein_12_16-3">16.3</a></sup> <sup><a href="#cite_ref-goldstein_12_16-4">16.4</a></sup></span> <span class="reference-text">Goldstein DA, Birnbaum AD, Tessler HH. Fuchs’ heterochromic Iridocyclitis. In: Cornea – 3rd Ed. Krachmer JH, Mannis MJ, Holland EJ, editors. Amsterdam: Elsevier; 2011. P.1307-10.</span>
</li>
<li id="cite_note-jones_13-17"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-jones_13_17-0">17.0</a></sup> <sup><a href="#cite_ref-jones_13_17-1">17.1</a></sup> <sup><a href="#cite_ref-jones_13_17-2">17.2</a></sup></span> <span class="reference-text">Jones NP. Fuchs’ heterochromic uveitis: an update. Surv Ophthalmol 1993; 37:253-72.</span>
</li>
<li id="cite_note-arif_14-18"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-arif_14_18-0">18.0</a></sup> <sup><a href="#cite_ref-arif_14_18-1">18.1</a></sup> <sup><a href="#cite_ref-arif_14_18-2">18.2</a></sup></span> <span class="reference-text">Arif M. Fuchs heterochromic uveitis. Medscape. Roy Sr H, editor. Updated Apr 20, 2010. Accessed Aug 8, 2011.</span>
</li>
<li id="cite_note-ram_15-19"><span class="mw-cite-backlink"><a href="#cite_ref-ram_15_19-0">↑</a></span> <span class="reference-text">Ram J, Kaushik S, Brar GS, et al. Phacoemulsification in patients with Fuchs’ heterochromic uveitis. J Cataract Refract Surg 2002; 28:1372-8.</span>
</li>
<li id="cite_note-scott_16-20"><span class="mw-cite-backlink"><a href="#cite_ref-scott_16_20-0">↑</a></span> <span class="reference-text">Scott RA, Sullivan PM, Aylward GW, et al. The effect of pars plana vitrectomy in the management of Fuchs heterochromic cyclitis. Retina 2001; 21:312-6.</span>
</li>
<li id="cite_note-lahey_17-21"><span class="mw-cite-backlink"><a href="#cite_ref-lahey_17_21-0">↑</a></span> <span class="reference-text">La Hey E, de Vries, J, Langerhorst CT, et al. Treatment and prognosis of secondary glaucoma in Fuchs’ heterochromic Iridocyclitis. Am J Ophthalmol 1993; 116:327-40.</span>
</li>
<li id="cite_note-jones_18-22"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-jones_18_22-0">22.0</a></sup> <sup><a href="#cite_ref-jones_18_22-1">22.1</a></sup></span> <span class="reference-text">Jones NP. Glaucoma in Fuchs’ heterochromic uveitis: aetiology, management and outcome. Eye 1991; 5:662-7.</span>
</li>
<li id="cite_note-liesegang_19-23"><span class="mw-cite-backlink"><a href="#cite_ref-liesegang_19_23-0">↑</a></span> <span class="reference-text">Liesegang TS. Clinical features and prognosis in Fuchs’ uveitis syndrome. Arch Ophthalmol 1982; 100:1622-6.</span>
</li>
<li id="cite_note-tabbut_20-24"><span class="mw-cite-backlink"><a href="#cite_ref-tabbut_20_24-0">↑</a></span> <span class="reference-text">Tabbut BR, Tessles HH, Williams D. Fuchs’ heterochromic Iridocyclitis in blacks. Arch Ophthalmol 1988; 106:1688-90.</span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><a href="#cite_ref-25">↑</a></span> <span class="reference-text">Toniolo, Jason T., Anthony J. Hall, Jennifer G. Smith, Jaime Levy, and Lyndell L. Lim. 2017. “Risk Factors for Glaucoma in a Cohort of Patients with Fuchs Heterochromic Iridocyclitis.” <i>Ocular Immunology and Inflammation</i> 25 (6): 753–59</span>
</li>
<li id="cite_note-26"><span class="mw-cite-backlink"><a href="#cite_ref-26">↑</a></span> <span class="reference-text">Touhami, Sara, Antoine Vanier, Alessandra Rosati, Magdalena Bojanova, Bouchra Benromdhane, Phuc Lehoang, Flore Rozenberg, and Bahram Bodaghi. 2019. “Predictive Factors of Intraocular Pressure Level Evolution over Time and Glaucoma Severity in Fuchs’ Heterochromic Iridocyclitis.” <i>Investigative Ophthalmology &amp; Visual Science</i> 60 (7): 2399–2405.</span>
</li>
<li id="cite_note-27"><span class="mw-cite-backlink"><a href="#cite_ref-27">↑</a></span> <span class="reference-text">Almobarak, Faisal A., Ali H. Alharbi, Jose Morales, and Ibrahim Aljadaan. 2017. “Intermediate and Long-Term Outcomes of Mitomycin C-Enhanced Trabeculectomy as a First Glaucoma Procedure in Uveitic Glaucoma.” <i>Journal of Glaucoma</i> 26 (5): 478–85.</span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><a href="#cite_ref-28">↑</a></span> <span class="reference-text">Muñoz-Negrete, Francisco J., Javier Moreno-Montañés, Paula Hernández-Martínez, and Gema Rebolleda. 2015. “Current Approach in the Diagnosis and Management of Uveitic Glaucoma.” <i>BioMed Research International</i>2015 (October): 742792.</span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><a href="#cite_ref-29">↑</a></span> <span class="reference-text">La Hey E, Rothova A, Baarsma GS, et al. Fuchs’ heterochromic Iridocyclitis is not associated with ocular toxoplasmosis. Arch Ophthalmol 1992; 110:806-11.</span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><a href="#cite_ref-30">↑</a></span> <span class="reference-text">Towler HM, McCluskey P, Shaer B, et al. Long-term follow-up of trabeculectomy with intraoperative 5-fluorouracil for uveitis-related glaucoma. Ophthalmology 2000; 107:1822-8.</span>
</li>
<li id="cite_note-31"><span class="mw-cite-backlink"><a href="#cite_ref-31">↑</a></span> <span class="reference-text">Da Mata A, Burk SE, Netland PA, et al. Management of uveitic glaucoma with Ahmed glaucoma valve implantation. Ophthalmology 1999; 106:2168-72.</span>
</li>
<li id="cite_note-32"><span class="mw-cite-backlink"><a href="#cite_ref-32">↑</a></span> <span class="reference-text">Papadaki TG, Zacharopoulous IP, Pasquale LR, et al. Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol 2007; 144:62-9.</span>
</li>
<li id="cite_note-33"><span class="mw-cite-backlink"><a href="#cite_ref-33">↑</a></span> <span class="reference-text">Sung VCT, Barton K. Management of inflammatory glaucomas. Curr Opin Ophthalmol 2004; 15:136-40.</span>
</li>
<li id="cite_note-34"><span class="mw-cite-backlink"><a href="#cite_ref-34">↑</a></span> <span class="reference-text">You, Yi-An, Yaming Wu, and Saijing Hu. 2013. “Surgical Management of Secondary Glaucoma in Fuchs’ Heterochromic Iridocyclitis.” <i>Graefe s Archive for Clinical and Experimental Ophthalmology</i> 251 (7): 1785–90.</span>
</li>
<li id="cite_note-:2-35"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-:2_35-0">35.0</a></sup> <sup><a href="#cite_ref-:2_35-1">35.1</a></sup></span> <span class="reference-text">Walkden, Andrew, Karl Mercieca, Divya Perumal, and Nitin Anand. 2019. “Primary Glaucoma Surgery in Fuchs’ Heterochromic Uveitis: A Comparison of Trabeculectomy versus Deep Sclerectomy.” <i>Therapeutic Advances in Ophthalmology</i> 11 (January): 2515841419869761.</span>
</li>
<li id="cite_note-36"><span class="mw-cite-backlink"><a href="#cite_ref-36">↑</a></span> <span class="reference-text">Elgin, Ufuk, Emine Sen, Kubra Ozdemir, Pinar Ozdal, and Nilufer Berker. 2020. “The Outcome of Initial Mitomycin C-Augmented Trabeculectomy with Subconjunctival Bevacizumab in the Management of Secondary Glaucoma Associated with Fuchs Heterochromic Iridocyclitis.” <i>International Ophthalmology</i> 40 (4): 795–802.</span>
</li>
<li id="cite_note-37"><span class="mw-cite-backlink"><a href="#cite_ref-37">↑</a></span> <span class="reference-text">Esfandiari, Hamed, Nils A. Loewen, Kiana Hassanpour, Ali Fatourechi, Shahin Yazdani, Chao Wang, Mehdi Yaseri, and Mohammad Pakravan. 2018. “Fuchs Heterochromic Iridocyclitis-Associated Glaucoma: A Retrospective Comparison of Primary Ahmed Glaucoma Valve Implantation and Trabeculectomy with Mitomycin C.” <i>F1000Research</i> 7 (June): 876.</span>
</li>
<li id="cite_note-38"><span class="mw-cite-backlink"><a href="#cite_ref-38">↑</a></span> <span class="reference-text">Nilforushan, Naveed, Maryam Yadgari, and Sayyed Amirpooya Alemzadeh. 2019. “Surgical Management of Glaucoma in Fuchs Uveitis Syndrome: Trabeculectomy or Ahmed Glaucoma Valve.” <i>Journal of Current Ophthalmology</i> 31 (1): 24–30.</span>
</li>
</ol></div>
<!-- 
NewPP limit report
Cached time: 20230306035151
Cache expiry: 86400
Dynamic content: false
Complications: [my_variables_no_cache]
[SMW] In‐text annotation parser time: 0.001 seconds
CPU time usage: 0.250 seconds
Real time usage: 1.136 seconds
Preprocessor visited node count: 1164/1000000
Post‐expand include size: 8674/2097152 bytes
Template argument size: 2057/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 1/100
Unstrip recursion depth: 0/20
Unstrip post‐expand size: 19808/5000000 bytes
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  573.535      1 Template:Article
100.00%  573.535      1 -total
 92.87%  532.627      4 Template:Infobox_section
 48.27%  276.871     14 Template:UserLookup
  6.06%   34.780      1 Template:Review_expired
  4.13%   23.701      1 Template:Infobox_end
  0.45%    2.573      1 Template:Infobox_begin
  0.33%    1.908      1 Template:Get_active_contest
-->
</div></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://eyewiki.org/w/index.php?title=Fuchs_Heterochromic_Iridocyclitis&amp;oldid=87483">https://eyewiki.org/w/index.php?title=Fuchs_Heterochromic_Iridocyclitis&amp;oldid=87483</a>"</div>

						<!-- end body text -->
						<!-- data blocks which should go somewhere after the body text, but not before the catlinks block-->
						<div id='mw-data-after-content'>
	<div class="mw-cookiewarning-container"><div class="mw-cookiewarning-text"><span>The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.</span></div><form method="POST"><div class='oo-ui-layout oo-ui-horizontalLayout'><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-progressive oo-ui-buttonWidget'><a role='button' tabindex='0' aria-disabled='false' href='https://www.aao.org/privacy-policy' rel='nofollow' class='oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-progressive'></span><span class='oo-ui-labelElement-label'>Learn more</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-progressive'></span></a></span><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-inputWidget oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-primary oo-ui-flaggedElement-progressive oo-ui-buttonInputWidget'><button type='submit' tabindex='0' aria-disabled='false' name='disablecookiewarning' value='OK' class='oo-ui-inputWidget-input oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-invert'></span><span class='oo-ui-labelElement-label'>Accept</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-invert'></span></button></span></div></form></div>
</div>

					</div>
					<!-- category links -->
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/Special:Categories" title="Special:Categories">Categories</a>: <ul><li><a href="/Category:Articles" title="Category:Articles">Articles</a></li><li><a href="/Category:Glaucoma" title="Category:Glaucoma">Glaucoma</a></li><li><a href="/Category:Uveitis" title="Category:Uveitis">Uveitis</a></li></ul></div></div>
				</div>
			</div>
		</div>
	</div>
	<div class="mb-2 mt-4 footer container">
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar not-collapsible small mb-2" role="navigation" id="mw-navigation-hbpzytk89w">
					<div class="navbar-nav">
					<!-- toolbox -->
					<div id="t-whatlinkshere" class="nav-item"><a href="/Special:WhatLinksHere/Fuchs_Heterochromic_Iridocyclitis" title="A list of all wiki pages that link here [j]" accesskey="j" class="nav-link t-whatlinkshere">What links here</a></div>
					<div id="t-recentchangeslinked" class="nav-item"><a href="/Special:RecentChangesLinked/Fuchs_Heterochromic_Iridocyclitis" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k" class="nav-link t-recentchangeslinked">Related changes</a></div>
					<div id="t-specialpages" class="nav-item"><a href="/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q" class="nav-link t-specialpages">Special pages</a></div>
					<div id="t-print" class="nav-item"><a href="javascript:print();" rel="alternate" title="Printable version of this page [p]" accesskey="p" class="nav-link t-print">Printable version</a></div>
					<div id="t-permalink" class="nav-item"><a href="/w/index.php?title=Fuchs_Heterochromic_Iridocyclitis&amp;oldid=87483" title="Permanent link to this revision of the page" class="nav-link t-permalink">Permanent link</a></div>
					<div id="t-info" class="nav-item"><a href="/w/index.php?title=Fuchs_Heterochromic_Iridocyclitis&amp;action=info" title="More information about this page" class="nav-link t-info">Page information</a></div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- footer links -->
				<div id="footer-info" class="footer-info">
					<!-- info -->
					<div> This page was last edited on December 20, 2022, at 12:14.</div>
					<div>This page has been accessed 240,352 times.</div>
				</div>
				<!-- places -->
				<div id="footer-places" class="footer-places">
					<div><a href="/EyeWiki:Privacy_policy" title="EyeWiki:Privacy policy">Privacy policy</a></div>
					<div><a href="/EyeWiki:About" title="EyeWiki:About">About EyeWiki</a></div>
					<div><a href="/EyeWiki:General_disclaimer" title="EyeWiki:General disclaimer">Disclaimers</a></div>
				</div>
			</div>
			<div class="col">
				<!-- footer icons -->
				<div id="footer-icons" class="justify-content-end footer-icons">
					<!-- poweredby -->
					<div><a href="https://www.mediawiki.org/"><img src="/w/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/w/resources/assets/poweredby_mediawiki_132x47.png 1.5x, /w/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"/></a></div>
					<div><a href="https://www.semantic-mediawiki.org/wiki/Semantic_MediaWiki"><img src="data:image/png;base64,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" alt="Powered by Semantic MediaWiki" class="smw-footer" width="88" height="31" loading="lazy"/></a></div>
				</div>
			</div>
		</div>
	</div>
<script src="https://www.googletagmanager.com/gtag/js?id=UA-64665049-1" async=""></script><script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'UA-64665049-1', {});
</script>

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"smw":{"limitreport-intext-parsertime":0.001},"limitreport":{"cputime":"0.250","walltime":"1.136","ppvisitednodes":{"value":1164,"limit":1000000},"postexpandincludesize":{"value":8674,"limit":2097152},"templateargumentsize":{"value":2057,"limit":2097152},"expansiondepth":{"value":11,"limit":40},"expensivefunctioncount":{"value":1,"limit":100},"unstrip-depth":{"value":0,"limit":20},"unstrip-size":{"value":19808,"limit":5000000},"timingprofile":["100.00%  573.535      1 Template:Article","100.00%  573.535      1 -total"," 92.87%  532.627      4 Template:Infobox_section"," 48.27%  276.871     14 Template:UserLookup","  6.06%   34.780      1 Template:Review_expired","  4.13%   23.701      1 Template:Infobox_end","  0.45%    2.573      1 Template:Infobox_begin","  0.33%    1.908      1 Template:Get_active_contest"]},"cachereport":{"timestamp":"20230306035151","ttl":86400,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":1508});});</script></body>
</html>